MeiraGTx Holdings (MGTX) Cash from Investing Activities (2017 - 2025)

MeiraGTx Holdings (MGTX) posted Cash from Investing Activities of -$1.1 million for Q4 2025, down 99.09% on a QoQ basis from -$547000.0 in Q3 2025, and up 10.59% year-over-year from -$984708.2 in Q4 2024.

MeiraGTx Holdings (MGTX) Cash from Investing Activities (2017 - 2025) Analysis & Trends

MeiraGTx Holdings' Cash from Investing Activities history runs 9 years deep, the most recent figure standing at -$1.1 million for Q4 2025.

  • Quarterly Cash from Investing Activities rose 10.59% year-over-year to -$1.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$4.1 million (down 117.49% YoY) and the FY2025 annual result came in at -$4.1 million, down 117.49% from the prior year.
  • Cash from Investing Activities was -$1.1 million for Q4 2025 at MeiraGTx Holdings, down from -$547000.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $51.2 million in Q4 2023 and bottomed at -$25.4 million in Q4 2021.
  • A 5-year average of -$2.7 million and a median of -$4.3 million in 2023 frame the typical range for Cash from Investing Activities.
  • Annual changes were most pronounced in 2021 — Cash from Investing Activities plunged 367.49% — and 2023, when it jumped 702.66%.
  • MeiraGTx Holdings' Cash from Investing Activities stood at -$25.4 million in 2021, then surged by 66.53% to -$8.5 million in 2022, then soared by 702.66% to $51.2 million in 2023, then slumped by 102.38% to -$1.2 million in 2024, then increased by 10.59% to -$1.1 million in 2025.
  • Business Quant data shows MGTX's Cash from Investing Activities at -$1.1 million in Q4 2025, -$547000.0 in Q3 2025, and -$761000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -45.51 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -431.90 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -428.90 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 172.62 Mn
10 MeiraGTx Holdings 997.33 Mn 931.40 Mn - -1.09 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -1.09 Mn
Dec 31, 2025 -1.09 Mn
Sep 30, 2025 -547,000.00
Sep 30, 2025 -547,000.00
Jun 30, 2025 -761,000.00
Jun 30, 2025 -761,000.00
Mar 31, 2025 -1.71 Mn
Mar 31, 2025 -1.71 Mn
Dec 31, 2024 -1.22 Mn
Dec 31, 2024 -1.22 Mn
Sep 30, 2024 -1.31 Mn
Sep 30, 2024 -1.31 Mn
Jun 30, 2024 -1.33 Mn
Jun 30, 2024 -1.33 Mn
Mar 31, 2024 27.34 Mn
Mar 31, 2024 27.34 Mn
Dec 31, 2023 51.18 Mn
Dec 31, 2023 51.18 Mn
Sep 30, 2023 -3.56 Mn
Sep 30, 2023 -3.56 Mn